drugset / Trial / NCT01211873
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
RandomizedParallel-groupQuadruple-blindDiagnostic
Summary
The purpose of this study is to look at the safety (what are the side effects)and efficacy (how well does it work) of Dotarem® when used in taking images of the brain / spine. The results will be compared to the results of MRI taken without Dotarem.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gadopentetate dimeglumine | Diagnostic / imaging agent | 0.1 unknown | Intravenous |
| Subject | Gadoterate meglumine | Diagnostic / imaging agent | 0.1 unknown | Intravenous |